Clinical trial
A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic…
NCT00168441 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00168441 |
|---|---|
| Title | A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postherpetic Neuralgia |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A |
| Enrollment | 117 |
| Start date | Jun 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 30, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: